2001
MR Renography with Low-Dose Gadopentetate Dimeglumine: Feasibility
Lee V, Rusinek H, Johnson G, Rofsky N, Krinsky G, Weinreb J. MR Renography with Low-Dose Gadopentetate Dimeglumine: Feasibility. Radiology 2001, 221: 371-9. PMID: 11687678, DOI: 10.1148/radiol.2212010142.Peer-Reviewed Original ResearchConceptsRenal artery stenosisACE inhibitorsCreatinine levelsIntravenous injectionMedullary enhancementMR renographyAngiotensin converting enzyme (ACE) inhibitorsGadopentetate dimeglumineMR angiographyContrast material-enhanced MR angiographyElevated creatinine levelSerum creatinine levelsMaterial-enhanced MR angiographyConverting Enzyme InhibitorsGadolinium-enhanced MR angiographyRenographic findingsRenovascular diseaseRenal functionArtery stenosisRenal cortexPatientsEnzyme inhibitorsContrast materialClinical settingRenography
2000
Hepatic MR Imaging with a Dynamic Contrast-enhanced Isotropic Volumetric Interpolated Breath-hold Examination: Feasibility, Reproducibility, and Technical Quality
Lee V, Lavelle M, Rofsky N, Laub G, Thomasson D, Krinsky G, Weinreb J. Hepatic MR Imaging with a Dynamic Contrast-enhanced Isotropic Volumetric Interpolated Breath-hold Examination: Feasibility, Reproducibility, and Technical Quality. Radiology 2000, 215: 365-72. PMID: 10796909, DOI: 10.1148/radiology.215.2.r00ma16365.Peer-Reviewed Original ResearchMeSH KeywordsAdipose TissueAdultAgedAged, 80 and overCohort StudiesContrast MediaFeasibility StudiesFemaleFollow-Up StudiesGadolinium DTPAHepatic ArteryHepatic VeinsHumansImage EnhancementImage Processing, Computer-AssistedLiverLiver DiseasesMagnetic Resonance ImagingMaleMiddle AgedPortal VeinQuality ControlReproducibility of ResultsRespirationVena Cava, InferiorConceptsContrast materialMagnetic resonance imaging examinationsPatient underwent repeatVascular anatomic variantsDynamic contrastPortal venous phaseArterial dominanceUnderwent repeatVenous anatomyAnatomic variantsImaging examinationsTest bolusTest doseVenous phaseArterial phaseRepeat studyHepatic MRGadopentetate dimeglumineGradient-echo imagingTechnical qualityEnhanced acquisitionMaximal enhancementBreath-hold imagesOriginal study
1999
Single-Dose Breath-hold Gadolinium-enhanced Three-dimensional MR Angiography of the Renal Arteries
Lee V, Rofsky N, Krinsky G, Stemerman D, Weinreb J. Single-Dose Breath-hold Gadolinium-enhanced Three-dimensional MR Angiography of the Renal Arteries. Radiology 1999, 211: 69-78. PMID: 10189455, DOI: 10.1148/radiology.211.1.r99ap4869.Peer-Reviewed Original ResearchConceptsArterial enhancement ratioVenous enhancementRenal arteryTiming examinationContrast materialVascular enhancementMR angiographyBreath holdingContrast material administrationMagnetic resonance angiographyBreath-hold gadoliniumThree-dimensional magnetic resonance angiographyThree-dimensional MR angiographyRenal MR angiographyTest doseArterial enhancementResonance angiographyGadopentetate dimeglumineMaterial administrationAngiographyGradient-echo imagingEnhancement ratioSignificant differencesArteryAorta
1997
Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography.
Rofsky N, Johnson G, Adelman M, Rosen R, Krinsky G, Weinreb J. Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography. Radiology 1997, 205: 163-9. PMID: 9314979, DOI: 10.1148/radiology.205.1.9314979.Peer-Reviewed Original ResearchConceptsPeripheral vascular diseaseGadolinium-enhanced MR angiographyDigital subtraction angiographyVascular diseaseMR angiographyGadopentetate dimeglumineLower extremity peripheral vascular diseasePeripheral vascular areasExtent of diseaseMR angiography findingsGadolinium-enhanced magnetic resonance angiographyMagnetic resonance angiographyConventional digital subtraction angiographyStandard of referenceAngiography findingsMost patientsLess stenosisTreatment optionsLower extremitiesDSA findingsVascular areaAngiographyAnatomic segmentsAnatomic areasContrast materialSuppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine.
Rofsky N, Purdy D, Johnson G, DeCorato D, Earls J, Krinsky G, Weinreb J. Suppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine. Radiology 1997, 202: 177-82. PMID: 8988209, DOI: 10.1148/radiology.202.1.8988209.Peer-Reviewed Original ResearchConceptsGadopentetate dimeglumineLower extremitiesMR angiographyPeripheral vascular diseaseVenous signalDistal lower extremityMR angiogramsGadopentetate dimeglumine administrationStudent's t-testFlight MR angiographyAdult patientsAngiography timeVascular diseaseFlight MR angiogramsGradient echo sequenceAdministrationDimegluminePatientsAngiographyT-testAngiogramsExtremitiesMuscle tissueVenous suppressionImaging sectionsThoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging.
Krinsky G, Rofsky N, DeCorato D, Weinreb J, Earls J, Flyer M, Galloway A, Colvin S. Thoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging. Radiology 1997, 202: 183-93. PMID: 8988210, DOI: 10.1148/radiology.202.1.8988210.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAorta, ThoracicAortic Aneurysm, ThoracicAortic CoarctationAortic DiseasesAortic DissectionContrast MediaDrug CombinationsFemaleGadoliniumGadolinium DTPAHumansImage Processing, Computer-AssistedInfant, NewbornMagnetic Resonance AngiographyMagnetic Resonance ImagingMaleMeglumineMiddle AgedOrganometallic CompoundsPentetic AcidRetrospective StudiesConceptsThoracic aortic diseaseThree-dimensional MR angiographyConventional MR imagingMR angiographyIntramural hematomaAortic dissectionAortic diseaseVessel diseaseMR imagingFindings of surgeryChronic aortic dissectionThoracic MR imagingComparison of gadoliniumMagnetic resonance angiographyThree-dimensional magnetic resonance angiographyDiagnosis of aneurysmConsecutive patientsAngiographyResonance angiographyMR examinationsGadopentetate dimeglumineReader B.DiseaseGradient echo sequenceConventional MR
1995
Effect of magnetic resonance exposure combined with gadopentetate dimeglumine on chromosomes in animal specimens
Rofsky N, Pizzarello D, Duhaney M, Falick A, Prendergast N, Weinreb J. Effect of magnetic resonance exposure combined with gadopentetate dimeglumine on chromosomes in animal specimens. Academic Radiology 1995, 2: 492-496. PMID: 9419596, DOI: 10.1016/s1076-6332(05)80405-2.Peer-Reviewed Original Research
1994
Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine
Rofsky N, Pizzarello D, Weinreb J, Ambrosino M, Rosenberg C. Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine. Journal Of Magnetic Resonance Imaging 1994, 4: 805-807. PMID: 7865940, DOI: 10.1002/jmri.1880040611.Peer-Reviewed Original ResearchMeSH KeywordsAnalysis of VarianceAnimalsBody WeightContrast MediaDrug CombinationsEar, ExternalEmbryonic and Fetal DevelopmentExtremitiesEyeFemaleFetal DeathGadoliniumGadolinium DTPAGestational AgeHeadLitter SizeMagnetic Resonance ImagingMeglumineMiceOrganometallic CompoundsPentetic AcidPregnancySodium ChlorideConceptsDays of gestationIntraperitoneal injectionGadopentetate dimeglumineFetal weightEnd pointMR exposureMean fetal weightSaline injection groupMagnetic resonance exposurePregnant miceNormal salineFetal mouse developmentGroup 2Group 1Group 3Control groupGroup 4Group 5MR imagingAdverse effectsDimeglumineSignificant differencesGestationFetusesInjection
1993
Quantitative analysis of gadopentetate dimeglumine excreted in breast milk
Rofsky N, Weinreb J, Litt A. Quantitative analysis of gadopentetate dimeglumine excreted in breast milk. Journal Of Magnetic Resonance Imaging 1993, 3: 131-132. PMID: 8428080, DOI: 10.1002/jmri.1880030122.Peer-Reviewed Original Research
1991
Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency.
Rofsky N, Weinreb J, Bosniak M, Libes R, Birnbaum B. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Radiology 1991, 180: 85-9. PMID: 2052729, DOI: 10.1148/radiology.180.1.2052729.Peer-Reviewed Original ResearchConceptsRenal insufficiencyGadolinium-enhanced MR imagingRenal lesionsComputed tomographyGadolinium administrationBenign cystsMR imagingSerum creatine levelsTime of nephrectomyNonenhanced Computed TomographyRenal cell carcinomaT1-weighted magnetic resonanceRenal lesion characterizationFifth patientPathologic examinationNephrotoxic reactionsUsual dosageCell carcinomaIntravenous administrationCreatine levelsMagnetic resonancePatientsIntravenous gadoliniumLesionsGadopentetate dimeglumine